150 related articles for article (PubMed ID: 31770197)
1. Clinical significance of down-regulated HINT2 in hepatocellular carcinoma.
Zhou DK; Qian XH; Cheng J; Chen LH; Wang WL
Medicine (Baltimore); 2019 Nov; 98(48):e17815. PubMed ID: 31770197
[TBL] [Abstract][Full Text] [Related]
2. Decrease expression and clinicopathological significance of miR-148a with poor survival in hepatocellular carcinoma tissues.
Ajdarkosh H; Dadpay M; Yahaghi E; Pirzaman ER; Fayyaz AF; Darian EK; Mokarizadeh A
Diagn Pathol; 2015 Aug; 10():135. PubMed ID: 26248880
[TBL] [Abstract][Full Text] [Related]
3. Down-regulation of the tumour suppressor κ-opioid receptor predicts poor prognosis in hepatocellular carcinoma patients.
Chen D; Chen Y; Yan Y; Pan J; Xing W; Li Q; Zeng W
BMC Cancer; 2017 Aug; 17(1):553. PubMed ID: 28821282
[TBL] [Abstract][Full Text] [Related]
4. Downregulation of KIF1B mRNA in hepatocellular carcinoma tissues correlates with poor prognosis.
Yang SZ; Wang JT; Yu WW; Liu Q; Wu YF; Chen SG
World J Gastroenterol; 2015 Jul; 21(27):8418-24. PubMed ID: 26217094
[TBL] [Abstract][Full Text] [Related]
5. Up-Regulated Maternal Embryonic Leucine Zipper Kinase Predicts Poor Prognosis of Hepatocellular Carcinoma Patients in a Chinese Han Population.
Wu S; Chen X; Hu C; Wang J; Shen Y; Zhong Z
Med Sci Monit; 2017 Dec; 23():5705-5713. PubMed ID: 29192136
[TBL] [Abstract][Full Text] [Related]
6. Loss of SFRP1 Expression Is Associated with Poor Prognosis in Hepatocellular Carcinoma.
Davaadorj M; Imura S; Saito YU; Morine Y; Ikemoto T; Yamada S; Takasu C; Hiroki T; Yoshikawa M; Shimada M
Anticancer Res; 2016 Feb; 36(2):659-64. PubMed ID: 26851021
[TBL] [Abstract][Full Text] [Related]
7. DEP domain containing 1 is a novel diagnostic marker and prognostic predictor for hepatocellular carcinoma.
Yuan SG; Liao WJ; Yang JJ; Huang GJ; Huang ZQ
Asian Pac J Cancer Prev; 2014; 15(24):10917-22. PubMed ID: 25605201
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of phosphatidylinositol 4-kinase type IIIα is associated with undifferentiated status and poor prognosis of human hepatocellular carcinoma.
Ilboudo A; Nault JC; Dubois-Pot-Schneider H; Corlu A; Zucman-Rossi J; Samson M; Le Seyec J
BMC Cancer; 2014 Jan; 14():7. PubMed ID: 24393405
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-7 downregulates the oncogene VDAC1 to influence hepatocellular carcinoma proliferation and metastasis.
Wang F; Qiang Y; Zhu L; Jiang Y; Wang Y; Shao X; Yin L; Chen J; Chen Z
Tumour Biol; 2016 Aug; 37(8):10235-46. PubMed ID: 26831666
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of long non-coding RNA PCAT-1 expression in human hepatocellular carcinoma.
Yan TH; Yang H; Jiang JH; Lu SW; Peng CX; Que HX; Lu WL; Mao JF
Int J Clin Exp Pathol; 2015; 8(4):4126-31. PubMed ID: 26097602
[TBL] [Abstract][Full Text] [Related]
11. Hint2, a mitochondrial apoptotic sensitizer down-regulated in hepatocellular carcinoma.
Martin J; Magnino F; Schmidt K; Piguet AC; Lee JS; Semela D; St-Pierre MV; Ziemiecki A; Cassio D; Brenner C; Thorgeirsson SS; Dufour JF
Gastroenterology; 2006 Jun; 130(7):2179-88. PubMed ID: 16762638
[TBL] [Abstract][Full Text] [Related]
12. Revealing the clinical significance and prognostic value of small nucleolar RNA SNORD31 in hepatocellular carcinoma.
Ding Y; Sun Z; Zhang S; Xu Q; Zhou L; Zhou D; Li Y; Han X; Xu H; Bai Y; Xu C; Ding H; Ge Y; Wang W
Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 32697317
[TBL] [Abstract][Full Text] [Related]
13. Integrator complex subunit 6 (INTS6) inhibits hepatocellular carcinoma growth by Wnt pathway and serve as a prognostic marker.
Lui KY; Zhao H; Qiu C; Li C; Zhang Z; Peng H; Fu R; Chen HA; Lu MQ
BMC Cancer; 2017 Sep; 17(1):644. PubMed ID: 28899352
[TBL] [Abstract][Full Text] [Related]
14. Low CADM2 expression predicts high recurrence risk of hepatocellular carcinoma patients after hepatectomy.
Yang S; Yan HL; Tao QF; Yuan SX; Tang GN; Yang Y; Wang LL; Zhang YL; Sun SH; Zhou WP
J Cancer Res Clin Oncol; 2014 Jan; 140(1):109-16. PubMed ID: 24240726
[TBL] [Abstract][Full Text] [Related]
15. High expression of TACC2 in hepatocellular carcinoma is associated with poor prognosis.
Shakya M; Zhou A; Dai D; Zhong Q; Zhou Z; Zhang Y; Li X; Bholee AK; Chen M
Cancer Biomark; 2018; 22(4):611-619. PubMed ID: 29843208
[TBL] [Abstract][Full Text] [Related]
16. Neuron-glial antigen 2 overexpression in hepatocellular carcinoma predicts poor prognosis.
Lu LL; Sun J; Lai JJ; Jiang Y; Bai LH; Zhang LD
World J Gastroenterol; 2015 Jun; 21(21):6649-59. PubMed ID: 26074703
[TBL] [Abstract][Full Text] [Related]
17. Lin28B is an oncofetal circulating cancer stem cell-like marker associated with recurrence of hepatocellular carcinoma.
Cheng SW; Tsai HW; Lin YJ; Cheng PN; Chang YC; Yen CJ; Huang HP; Chuang YP; Chang TT; Lee CT; Chao A; Chou CY; Chan SH; Chow NH; Ho CL
PLoS One; 2013; 8(11):e80053. PubMed ID: 24244607
[TBL] [Abstract][Full Text] [Related]
18. LOXL4 is downregulated in hepatocellular carcinoma with a favorable prognosis.
Tian M; Liu W; Jin L; Jiang X; Yang L; Ding Z; Shen Y; Peng Y; Gao D; Li L; Zhou J; Qiu S; Dai Z; Fan J; Shi Y
Int J Clin Exp Pathol; 2015; 8(4):3892-900. PubMed ID: 26097573
[TBL] [Abstract][Full Text] [Related]
19. Up-regulation of miR-9 expression predicate advanced clinicopathological features and poor prognosis in patients with hepatocellular carcinoma.
Cai L; Cai X
Diagn Pathol; 2014 Dec; 9():1000. PubMed ID: 25552204
[TBL] [Abstract][Full Text] [Related]
20. Identification of recurrence-related microRNAs in hepatocellular carcinoma following liver transplantation.
Han ZB; Zhong L; Teng MJ; Fan JW; Tang HM; Wu JY; Chen HY; Wang ZW; Qiu GQ; Peng ZH
Mol Oncol; 2012 Aug; 6(4):445-57. PubMed ID: 22552153
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]